Use of central venous catheter-related bloodstream infection prevention practices by US hospitals

Mayo Clinic Proceedings

Volumn 82, Issue 6, 2007, Pages 672-678

  Krein, Sarah L ^a,b,e   Hofer, Timothy P ^a,b   Kowalski, Christine P ^a   Olmsted, Russell N ^c   Kauffman, Carol A ^a,b   Forman, Jane H ^a   Banaszak Holl, Jane ^d   Saint, Sanjay ^a,b  

^a VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c Saint Joseph Mercy Health System   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

^e VA HSR and D   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORHEXIDINE GLUCONATE;

ADULT; ARTICLE; BACTERIUM CULTURE; CATHETER INFECTION; CENTRAL VENOUS CATHETER; CENTRAL VENOUS CATHETERIZATION; HUMAN; HUMAN EXPERIMENT; INFECTION PREVENTION; INTENSIVE CARE UNIT; NORMAL HUMAN; OUTCOME ASSESSMENT; PATIENT SAFETY; PRIMARY PREVENTION; RANDOMIZATION; SAFETY; SCORING SYSTEM; SKIN DECONTAMINATION; UNITED STATES;

EID: 34249948114     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/82.6.672     Document Type: Article

References (54)

1. Stone PW, Hedblom EC, Murphy DM, Miller SB. The economic impact of infection control: making the business case for increased infection control resources. Am J Infect Control. 2005;33:542-547.
2. Richards MJ, Edwards JR, Culver DH, Gaynes RP. Nosocomial infections in medical intensive care units in the United States. Crit Care Med. 1999;27:887-892.
3. National Nosocomial Infections Surveillance (NNIS) report, data summary from October 1986-April 1997: issued May 1997. Am J Infect Control. 1997;25:477-487.
4. Kohn LT, Corrigan JM, Donaldson MS, eds. To Err is Human: Building a Safer Health System. Washington, DC: National Academy Press; 2000.
5. Pittet D. Infection control and quality health care in the new millennium. Am J Infect Control. 2005;33:258-267.
6. Eggimann P, Sax H, Pittet D. Catheter-related infections. Microbes Infect. 2004;6:1033-1042.
7. Kaoutar B, Joly C, L'Heriteau F, et al, French Hospital Mortality Study Group. Nosocomial infections and hospital mortality: a multicentre epidemiology study. J Hosp Infect. 2004;58:268-275.
8. Wenzel RP, Edmond MB. The impact of hospital-acquired bloodstream infections. Emerg Infect Dis. 2001;7:174-177.
9. Mermel LA. Prevention of intravascular catheter-related infections [published correction appears in Ann Intern Med. 2000;133:5]. Ann Intern Med. 2000;132:391-402.
10. Darouiche RO. Device-associated infections: a macroproblem that starts with microadherence. Clin Infect Dis. 2001 Nov 1;33:1567-1572. Epub 2001 Sep 26.
11. Vincent JL, Bihari DJ, Suter PM, et al, EPIC International Advisory Committee. The prevalence of nosocomial infection in intensive care units in Europe: results of the European Prevalence of Infection in Intensive Care (EPIC) study. JAMA. 1995;274:639-644.
12. Saint S, Veenstra DL, Lipsky BA. The clinical and economic consequences of nosocomial central venous catheter-related infection: are antimicrobial catheters useful? Infect Control Hosp Epidemiol. 2000;21:375-380.
13. Blot SI, Depuydt P, Annemans L, et al. Clinical and economic outcomes in critically ill patients with nosocomial catheter-related bloodstream infections. Clin Infect Dis. 2005 Dec 1;41:1591-1598. Epub 2005 Oct 25.
14. Pittet D, Tarara D, Wenzel RP. Nosocomial bloodstream infection in critically ill patients: excess length of stay, extra costs, and attributable mortality. JAMA. 1994;271:1598-1601.
15. Digiovine B, Chenoweth C, Watts C, Higgins M. The attributable mortality and costs of primary nosocomial bloodstream infections in the intensive care unit. Am J Respir Crit Care Med. 1999;160:976-981.
16. Harbath S, Sax H, Gastmeier P. The preventable proportion of nosocomial infections: an overview of published reports. J Hosp Infect. 2003;54:258-266.
17. Saint S. Prevention of intravascular catheter-associated infections. In: Shojania KG, Duncan BW, McDonald KM, Wachter RM, eds. Making Healthcare Safer: A Critical Analysis of Patient Safety Practices. Rockville, Md: US Dept of Health and Human Services, Agency for Healthcare Research and Quality; 2001:163-184. AHRQ Publication 01-E058.
18. O'Grady NP, Alexander M, Dellinger EP, et al. Centers for Disease Control and Prevention. Guidelines for the prevention of intravascular catheter-related infections. MMWR Recomm Rep. 2002;51:1-29.
19. Raad II, Hohn DC, Gilbreath BJ, et al. Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertion. Infect Control Hosp Epidemiol. 1994;15:231-238.
20. Hu KK, Lipsky BA, Veenstra DL, Saint S. Using maximal sterile barriers to prevent central venous catheter-related infection: a systematic evidence-based review. Am J Infect Control. 2004;32:142-146.
21. Maki DG, Ringer M, Alvarado CJ. Prospective randomised trial of povidone-iodine, alcohol, and chlorhexidine for prevention of infection associated with central venous and arterial catheters. Lancet. 1991;338:339-343.
22. Chaiyakunapruk N, Veenstra DL, Lipsky BA, Sullivan SD, Saint S. Vascular catheter site care: the clinical and economic benefits of chlorhexidine gluconate compared with povidone iodine. Clin Infect Dis. 2003 Sep 15: 37:764-771. Epub 2003 Aug 27.
23. Chaiyakunapruk N, Veenstra DL, Lipsky BA, Saint S. Chlorhexidine compared with povidone-iodine solution for vascular catheter-site care: a meta-analysis. Ann Intern Med. 2002;136:792-801.
24. Raad I, Darouiche R, Dupuis J, et al. Texas Medical Center Catheter Study Group. Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections: a randomized, double-blind trial. Ann Intern Med. 1997;127:267-274.
25. Boswald M, Lugauer S, Regenfus A, et al. Reduced rates of catheter-associated infection by use of a new silver-impregnated central venous catheter. Infection. 1999;27(suppl):S56-S60.
26. Veenstra DL, Saint S, Sana S, Lumley T, Sullivan SD. Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection: a mete-analysis. JAMA. 1999;281:261-267.
27. Veenstra DL, Saint S, Sullivan SD. Cost-effectiveness of antiseptic-impregnated central venous catheters for the prevention of catheter-related bloodstream infection. JAMA. 1999;282:554-560.
28. Safdar N, Maki DG. Lost in translation [editorial]. Infect Control Hosp Epidemiol. 2006 Jan;27:3-7. Epub 2006 Jan 6.
29. Lenfant C. Shattuck lecture - clinical research to clinical practice - lost in translation? N Engl J Med. 2003;349:868-874.
30. Berwick DM. Disseminating innovations in health care. JAMA. 2003;289:1969-1975.
31. Bero AL, Grilli R, Grimshaw JM, Harvey E, Oxman AD, Thomson MA. The Cochrane Effective Practice and Organization of Care Review Group. Closing the gap between research and practice: an overview of systematic reviews of interventions to promote the implementation of research findings. BMJ. 1998;317:465-468.
32. McGlynn EA, Asch SM, Adams J, et al. The quality of health care delivered to adults in the United States. N Engl J Med. 2003;348:2635-2645.
33. Warren DK, Yokoe DS, Climo MW, et al. Preventing catheter-associated bloodstream infections: a survey of policies for insertion and care of central venous catheters from hospitals in the prevention epicenter program. Infect Control Hosp Epidemiol. 2006 Jan;27:8-13. Epub 2006 Jan 6.
34. Rubinson L, Haponik EF, Wu AW, Diette GB. Internists' adherence to guidelines for prevention of intravascular catheter infections [letter]. JAMA. 2003;290:2802.
35. Itabinson L, Wu AW, Haponik EE, Diette GB. Why is it that internists do not follow guidelines for preventing intravascular catheter infections? Infect Control Hosp Epidemiol. 2005;26:525-533.
36. Pittet D. The Lowbury lecture: behaviour in infection control. J Hosp Infect. 2004;58:1-13.
37. Heyland DK, Cook DJ, Dodek PM. Prevention of ventilator-associated pneumonia: current practice in Canadian intensive care units. J Crit Care. 2002;17:161-167.
38. Rello J, Lorente C, Bodi M, Diaz E, Ricart M, Kollef MH. Why do physicians not follow evidence-based guidelines for preventing ventilator-associated pneumonia? a survey based on the opinions of an international panel of intensivists. Chest. 2002;122:656-661.
39. Kennedy AM, Elward AM, Fraser VJ. Survey of knowledge, beliefs, and practices of neonatal intensive care unit healthcare workers regarding nosocomial infections, central venous catheter care, and hand hygiene. Infect Control Hosp Epidemiol. 2004;25:747-752.
40. Berwick DM, Calkins DR, McCannon CJ, Hackbarth AD. The 100,000 lives campaign: setting a goal and a deadline for improving health care quality. JAMA. 2006;295:324-327.
41. Krein SL, Olmsted RN, Hofer TP, et al. Translating infection prevention evidence into practice using quantitative and qualitative research. Am J Infect Control. 2006;34:507-512.
42. Department of Health and Human Services, Health Resources and Services Administration. Area Resource File (ARF). Fairfax, Va: Quality Resource Systems; February 2003 release. Available at: www.arfsys.com/index.htm. Accessed May 8, 2007.
43. Rogers EM. Diffusion of Innovations. 5th ed. New York, NY: Free Press; 2003.
44. Perlin JB, Kolodner RM, Roswell RH. The Veterans Health Administration: quality, value, accountability, and information as transforming strategies for patient-centered care. Healthc Pap. 2005;5:10-24.
45. Kizer KW, Demakis JG, Feussner JR. Reinventing VA health care: systematizing quality improvement and quality innovation. Med Care. 2000; 38(suppl):I7-I16.
46. Pronovost P, Sexton B. Assessing safety culture: guidelines and recommendations [editorial]. Qual Saf Health Care. 2005;14:231-233.
47. Measurement-Excellence and Training Resource Information Center. Organizational Readiness for Evidence-based Health Care Interventions. Available at: www.hsrd.research.va.gov/for_researchers/measurement/instrument/ instrument_reviews2.cfm?detail=53. Accessed May 9, 2007.
48. Weeks WB, Bagian JP. Developing a culture of safety in the Veterans Health Administration. Eff Clin Pract. 2000;3:270-276.
49. Cicalini S, Palmieri F, Petrosillo N. Clinical review: new technologies for prevention of intravascular catheter-related infections. Crit Care. 2004 Jun;8:157-162. Epub 2004 Sep 29.
50. Garland JS, Alex CP, Mueller CD, et al. A randomized trial comparing povidone-iodine to a Chlorhexidine gluconate-impregnated dressing for prevention of central venous catheter infections in neonates. Pediatrics. 2001; 107:1431-1436.
51. Ruchlin HS, Dubbs NL, Callahan MA. The role of leadership in instilling a culture of safety: lessons from the literature. J Healthc Manag. 2004;49:47-58.
52. Certification Board of Infection Control and Epidemiology, Inc (CBIC). 2005. Available at www.cbic.org. Accessed April 13, 2007.
53. Gerberding JL. Hospital-onset infections: a patient safety issue. Ann Intern Med. 2002;137:665-670.
54. Burke JP. Patient safety: infection control - a problem for patient safety. N Engl J Med. 2003;348:651-656.